base on my calculation, the reasonable price should be around $8. As the price of 2021 September is $5.51, 2022 September annual report has revenue up 19.8 percent, ebitda up 59%. let's take a median of 19.8 and 59 equal to 39.4%. $5.51 ×1.394 = $7.68. please correct me if i am wrong. no wonder fda approved a2 baby formula in us and with the increase of milk price, the renenue would definitely go up next year but the edita is a question. i strongly believe that it is an undervalue stock. if the board can start the dividends, that would be fantastic.
anyone knows why a2m doesn't do dividends?
Ann: 2022 Annual Meeting, page-21
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$7.01 |
Change
0.290(4.32%) |
Mkt cap ! $5.067B | |||
| Open | High | Low | Value | Volume |
| $6.83 | $7.12 | $6.81 | $26.19M | 3.735M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2000 | $7.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $7.02 | 28521 | 7 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| A2M (ASX) Chart |